These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26287254)

  • 1. Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics.
    Sharma S; Zapatero-Rodríguez J; Estrela P; O'Kennedy R
    Biosensors (Basel); 2015 Aug; 5(3):577-601. PubMed ID: 26287254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic diagnostic technologies for global public health.
    Yager P; Edwards T; Fu E; Helton K; Nelson K; Tam MR; Weigl BH
    Nature; 2006 Jul; 442(7101):412-8. PubMed ID: 16871209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.
    Duchesne L; Lacombe K
    J Viral Hepat; 2018 Feb; 25(2):108-117. PubMed ID: 29134742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities and challenges for the application of microfluidic technologies in point-of-care veterinary diagnostics.
    Busin V; Wells B; Kersaudy-Kerhoas M; Shu W; Burgess ST
    Mol Cell Probes; 2016 Oct; 30(5):331-341. PubMed ID: 27430150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidics Based Point-of-Care Diagnostics.
    Pandey CM; Augustine S; Kumar S; Kumar S; Nara S; Srivastava S; Malhotra BD
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 29178532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic-integrated biosensors: prospects for point-of-care diagnostics.
    Kumar S; Kumar S; Ali MA; Anand P; Agrawal VV; John R; Maji S; Malhotra BD
    Biotechnol J; 2013 Nov; 8(11):1267-79. PubMed ID: 24019250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics-based diagnostics of infectious diseases in the developing world.
    Chin CD; Laksanasopin T; Cheung YK; Steinmiller D; Linder V; Parsa H; Wang J; Moore H; Rouse R; Umviligihozo G; Karita E; Mwambarangwe L; Braunstein SL; van de Wijgert J; Sahabo R; Justman JE; El-Sadr W; Sia SK
    Nat Med; 2011 Jul; 17(8):1015-9. PubMed ID: 21804541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in paper-based point-of-care diagnostics.
    Hu J; Wang S; Wang L; Li F; Pingguan-Murphy B; Lu TJ; Xu F
    Biosens Bioelectron; 2014 Apr; 54():585-97. PubMed ID: 24333570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious pathogens meet point-of-care diagnostics.
    Zarei M
    Biosens Bioelectron; 2018 May; 106():193-203. PubMed ID: 29428589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Low-Cost Microfluidic Detection in Point of Care Diagnostics.
    Raju SP; Chu X
    J Med Syst; 2018 Aug; 42(10):184. PubMed ID: 30167799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Enabling Technologies for Point-of-Care Diagnostics.
    Primiceri E; Chiriacò MS; Notarangelo FM; Crocamo A; Ardissino D; Cereda M; Bramanti AP; Bianchessi MA; Giannelli G; Maruccio G
    Sensors (Basel); 2018 Oct; 18(11):. PubMed ID: 30355989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional, inexpensive, and reusable nanoparticle-printed biochip for cell manipulation and diagnosis.
    Esfandyarpour R; DiDonato MJ; Yang Y; Durmus NG; Harris JS; Davis RW
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1306-E1315. PubMed ID: 28167769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic platform towards point-of-care diagnostics in infectious diseases.
    Su W; Gao X; Jiang L; Qin J
    J Chromatogr A; 2015 Jan; 1377():13-26. PubMed ID: 25544727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Materials for Microfluidic Immunoassays: A Review.
    Mou L; Jiang X
    Adv Healthc Mater; 2017 Aug; 6(15):. PubMed ID: 28322517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care diagnostics for sepsis using clinical biomarkers and microfluidic technology.
    Bradley Z; Bhalla N
    Biosens Bioelectron; 2023 May; 227():115181. PubMed ID: 36867959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future.
    Kozel TR; Burnham-Marusich AR
    J Clin Microbiol; 2017 Aug; 55(8):2313-2320. PubMed ID: 28539345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Potential Deployment of Biosensors for Point-of-Care Diagnostics in Developing Countries: Technological, Economic and Regulatory Aspects.
    Migliozzi D; Guibentif T
    Biosensors (Basel); 2018 Nov; 8(4):. PubMed ID: 30501052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.
    Lifson MA; Ozen MO; Inci F; Wang S; Inan H; Baday M; Henrich TJ; Demirci U
    Adv Drug Deliv Rev; 2016 Aug; 103():90-104. PubMed ID: 27262924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for overcoming challenges for decentralised diagnostics in resource-limited and catastrophe settings.
    Sharma S; Crawley A; O'Kennedy R
    Expert Rev Mol Diagn; 2017 Feb; 17(2):109-118. PubMed ID: 28010145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New nucleic acid testing devices to diagnose infectious diseases in resource-limited settings.
    Maffert P; Reverchon S; Nasser W; Rozand C; Abaibou H
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1717-1731. PubMed ID: 28573472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.